{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:44:11Z","timestamp":1790934251077,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union"},{"name":"AVIP"},{"name":"Swedish Embassy, Tanzania"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European & Developing Countries Clinical Trials Partnership {EDCTP}"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.001","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T05:46:56Z","timestamp":1314078416000},"page":"8417-8428","source":"Crossref","is-referenced-by-count":97,"title":["Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania"],"prefix":"10.1016","volume":"29","author":[{"given":"Muhammad","family":"Bakari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deus","family":"Buma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candida","family":"Moshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Aris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eligius F.","family":"Lyamuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Janabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Godoy-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agricola","family":"Joachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Polonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Br\u00e5ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Earl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Marovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Wahren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisali","family":"Pallangyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnel","family":"Biberfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Mhalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.001_bib0005","unstructured":"UNAIDS. UNAIDS report on the global AIDS epidemic; 2010. Available from: www.unaids.org\/globalreport\/Global_report.htm."},{"issue":"9","key":"10.1016\/j.vaccine.2011.08.001_bib0010","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/erv.10.106","article-title":"Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1","volume":"9","author":"Paris","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.001_bib0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/428405","article-title":"Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 in a phase 3 HIV-1 preventive vaccine trial","volume":"191","author":"Gilbert","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.001_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2796.2007.01820.x","article-title":"Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets","volume":"262","author":"Phogat","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0025","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/nm1212","article-title":"T cell vaccines for microbial infections","volume":"11","author":"Robinson","year":"2005","journal-title":"Nat Med"},{"issue":"5779","key":"10.1016\/j.vaccine.2011.08.001_bib0030","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1126\/science.1124226","article-title":"Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys","volume":"312","author":"Letvin","year":"2006","journal-title":"Science"},{"issue":"Pt8","key":"10.1016\/j.vaccine.2011.08.001_bib0035","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1099\/vir.0.79869-0","article-title":"Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen","volume":"85","author":"M\u00e4kitalo","year":"2004","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.001_bib0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/COH.0b013e32833d17ac","article-title":"HIV vaccines: lessons learned and the way forward","volume":"5","author":"Kim","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"10.1016\/j.vaccine.2011.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/509259","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine","volume":"194","author":"Graham","year":"2006","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2011.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective adenovirus vector","volume":"194","author":"Catanzaro","year":"2006","journal-title":"J Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2011.08.001_bib0055","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1016\/j.vaccine.2007.02.050","article-title":"Phase 1 clinical evaluation of a six-plasmid multiclade HIV-1 DNA vaccine candidate","volume":"25","author":"Catanzaro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0060","unstructured":"IAVI. Available from: www.iavireport.org\/trialsdb."},{"key":"10.1016\/j.vaccine.2011.08.001_bib0065","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","volume":"80","author":"Goonetilleke","year":"2006","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2011.08.001_bib0070","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.vaccine.2008.02.071","article-title":"Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa","volume":"26","author":"Jaoko","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.001_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20071331","article-title":"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"205","author":"Harari","year":"2008","journal-title":"J Exp Med"},{"issue":"25","key":"10.1016\/j.vaccine.2011.08.001_bib0080","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.vaccine.2008.02.072","article-title":"EV02: a phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone","volume":"26","author":"McCormack","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.08.001_bib0085","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/592507","article-title":"Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara","volume":"198","author":"Sandstr\u00f6m","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.001_bib0090","doi-asserted-by":"crossref","first-page":"e9015","DOI":"10.1371\/journal.pone.0009015","article-title":"Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses","volume":"5","author":"Koup","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.001_bib0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/650299","article-title":"A phase 1\/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-uninfected East Africans (RV172)","volume":"201","author":"Kibuuka","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.001_bib0100","doi-asserted-by":"crossref","first-page":"e8617","DOI":"10.1371\/journal.pone.0008617","article-title":"Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C\/B\u2032 HIV-1 candidate vaccine","volume":"5","author":"Vasan","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2011.08.001_bib0105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/aid.2009.0096","article-title":"A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers","volume":"25","author":"Ramanathan","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"10.1016\/j.vaccine.2011.08.001_bib0110","doi-asserted-by":"crossref","first-page":"e13983","DOI":"10.1371\/journal.pone.0013983","article-title":"Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia-Anlara-HIV-1 vaccine candidate","volume":"5","author":"Currier","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.001_bib0115","doi-asserted-by":"crossref","first-page":"e8816","DOI":"10.1371\/journal.pone.0008816","article-title":"Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B\u2032\/C candidate vaccine","volume":"5","author":"Vasan","year":"2010","journal-title":"PLoS One"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.08.001_bib0120","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiq105","article-title":"Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles","volume":"203","author":"Goepfert","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0125","doi-asserted-by":"crossref","unstructured":"Ramanathan VD, Mehendale S, Sahay S, Thakar M, Makeshkumar M, Sathyamurthi P, et al. Safety and immunogenicity of DNA prime and modified vaccinia Ankara virus HIV subtype C vaccine boost in Indian volunteers. AIDS vaccine 2010, Atlanta, GA, USA, 28 September\u20131 October 2010. AIDS Res Hum Retroviruses 26(10):A-1\u2013184.","DOI":"10.1089\/aid.2010.9998"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.001_bib0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1473-3099(10)70069-4","article-title":"Progress towards development of an HIV vaccine: report of the AIDS vaccine 2009 conference","volume":"10","author":"Ross","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"9653","key":"10.1016\/j.vaccine.2011.08.001_bib0135","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomized, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2011.08.001_bib0140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/QAD.0b013e3283379712","article-title":"Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies","volume":"24","author":"D'souza","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0145","unstructured":"HVTN 505. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00865566."},{"key":"10.1016\/j.vaccine.2011.08.001_bib0150","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand","volume":"194","author":"Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2011.08.001_bib0155","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.08.001_bib0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00002030-200002180-00014","article-title":"The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania: a potential population for HIV vaccine trials","volume":"14","author":"Bakari","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0165","article-title":"Prevalence of genotypic resistance to antiretroviral drugs in treatment-na\u00efve youths infected with diverse HIV type 1 subtypes and recombinant forms in Dar es Salaam, Tanzania","author":"Mosha","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/0889222041725235","article-title":"HIV type 1 subtypes among blood donors in the Mbeya region of Southwest Tanzania","volume":"20","author":"Arroyo","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"10.1016\/j.vaccine.2011.08.001_bib0175","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ymthe.2005.06.473","article-title":"Multigene\/multi-clade HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery","volume":"12","author":"Br\u00e5ve","year":"2005","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2011.08.001_bib0180","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/sj.mt.6300235","article-title":"A new multi-clade DNA prime\/recombinant MVA boost vaccine induces broad and high levels of HIV-1 specific CD8+ T-cell and humoral responses in mice","volume":"15","author":"Br\u00e5ve","year":"2007","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.001_bib0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/viro.2002.1547","article-title":"Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes","volume":"302","author":"Ljungberg","year":"2002","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2011.08.001_bib0190","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1016\/j.vaccine.2005.08.018","article-title":"Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine","volume":"24","author":"Br\u00e5ve","year":"2006","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2011.08.001_bib0195","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1016\/j.vaccine.2009.07.039","article-title":"Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines","volume":"27","author":"Earl","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0200","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2004.05.004","article-title":"Incidence and follow-up of inflammatory cardiac complication s after smallpox vaccination","volume":"44","author":"Eckart","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.001_bib0210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/CVI.00161-07","article-title":"Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects","volume":"15","author":"Nilsson","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.08.001_bib0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"Currier","year":"2002","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.vaccine.2011.08.001_bib0220","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1128\/CVI.00008-10","article-title":"Strong HIV-specific CD4+ and CD8+ T lymphocyte proliferative responses in healthy individuals immunized with a HIV-1 DNA vaccine and boosted with HIV-1 recombinant modified vaccinia virus Ankara (MVA)","volume":"17","author":"Aboud","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.001_bib0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jviromet.2006.03.005","article-title":"Evaluation of HIV antibody and antigen\/antibody combination ELISAs for use in an alternative confirmatory HIV testing strategy in Dar es Salaam, Tanzania","volume":"135","author":"Aboud","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0230","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1211s64","article-title":"Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays","author":"Montefiori","year":"2004","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.08.028","article-title":"Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC","volume":"408","author":"Edmonds","year":"2010","journal-title":"Virology"},{"issue":"33","key":"10.1016\/j.vaccine.2011.08.001_bib0240","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1016\/j.vaccine.2009.05.018","article-title":"Recombinant modified vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity","volume":"27","author":"Gudmundsdotter","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.001_bib0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAI.0b013e3180417cb6","article-title":"Safety and immunogenicity of a Gag\u2013Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1 seronegative subjects","volume":"44","author":"Tavel","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0250","first-page":"83","article-title":"Needle-free injection of DNA vaccines: a brief overview and methodology","volume":"127","author":"Raviprakash","year":"2006","journal-title":"Methods Mol Med"},{"issue":"8","key":"10.1016\/j.vaccine.2011.08.001_bib0255","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"23","key":"10.1016\/j.vaccine.2011.08.001_bib0260","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies","volume":"78","author":"Binley","year":"2004","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.08.001_bib0265","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1128\/JVI.79.10.6089-6101.2005","article-title":"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","volume":"79","author":"Brown","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.001_bib0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2007.01.015","article-title":"Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies","volume":"363","author":"Choudhry","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination","volume":"375","author":"Polonis","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.08.001_bib0280","first-page":"2","article-title":"Willingness to volunteer in a phase I\/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania","author":"Tarimo","year":"2009","journal-title":"Glob Health Action"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T10:00:09Z","timestamp":1638352809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11012102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":56,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11012102"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}